Search Results 61-70 of 26207 for ulcerative colitis

  1. centers-of-excellence

    Ulcerative colitis care at Mayo Clinic Your Mayo Clinic care team Treating ulcerative colitis involves specialists in gastroenterology and hepatology, colon and ...

  2. Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC). Participation eligibility. Participant ...

  3. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

  4. Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  5. Crohn's disease - Diagnosis and treatment - Mayo Clinic

    Look for information from the Crohn's & Colitis Foundation. Join a support group. Although support groups aren't for everyone, they can provide valuable ...

  6. Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  7. Scott Hennen on Ulcerative Colitis and Mayo Clinic

    ... ulcerative colitis, which was first diagnosed in 1997. Scott had previously described his reasons for being public about his medical condition in this post ...

  8. Evaluation of the Relationship Between Pouch Function and Pouch Inflammation in Patients with Ulcerative Colitis - Mayo Clinic

    Evaluation of the Relationship Between Pouch Function and Pouch Inflammation in Patients with Ulcerative Colitis · Overview · Participation eligibility.

  9. Mesalamine (Oral Route) Proper Use - Mayo Clinic

    Dosing · For the treatment of ulcerative colitis: For long-acting oral dosage form (delayed-release capsules):. Adults—800 milligrams (mg) 3 times a day. · For ...

  10. Inflammatory Bowel Disease Diagnoses Rising - Mayo Clinic News Network

    ... ulcerative colitis – the main conditions that comprise inflammatory bowel disease (IBD) – are on the rise. “More people are being diagnosed with IBD than 15 ...